Tech Company Financing Transactions
CyVek Funding Round
On 1/13/2014, CyVek announced $1.9 million in funding from private investors.
Transaction Overview
Company Name
Announced On
1/13/2014
Transaction Type
Debt
Amount
$1,854,410
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2 Barnes Industrial Road South
Wallingford, CT 06492
USA
Wallingford, CT 06492
USA
Phone
Website
Email Address
Overview
The objective of the CyVek technology is to provide a robust platform for multiplexed proteomics, particularly to serve the market needs of biomarker validation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Per Hellsund
Chief Technical Officer
Marty Putnam
VP - Bus. Development
Rajiv Pande
Browse more venture capital transactions:
Prev: 1/13/2014: DxNA venture capital transaction
Next: 1/13/2014: Pinta Biotherapeutics venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs